标题
Metformin as a Therapeutic Target in Endometrial Cancers
作者
关键词
-
出版物
Frontiers in Oncology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-08-28
DOI
10.3389/fonc.2018.00341
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy
- (2018) Dayana B. Rivadeneira et al. CLINICAL CANCER RESEARCH
- Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization
- (2018) Ji-Chang Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways
- (2018) Yan Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metformin, other antidiabetic drugs, and endometrial cancer risk
- (2017) Matteo Franchi et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Effects of metformin on endometrial cancer: Systematic review and meta-analysis
- (2017) Cinthia G. Meireles et al. GYNECOLOGIC ONCOLOGY
- Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication
- (2017) R. Arima et al. GYNECOLOGIC ONCOLOGY
- Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling
- (2017) Yan Zhao et al. GYNECOLOGICAL ENDOCRINOLOGY
- Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
- (2017) Joseph Curry et al. LARYNGOSCOPE
- Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells
- (2017) Jingbo Zhang et al. Oncology Letters
- The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy
- (2017) Yaojie Fu et al. Oncotarget
- Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
- (2017) Yun-Liang Tang et al. Biomed Research International
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer
- (2017) John J. Wallbillich et al. PLoS One
- Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review
- (2016) Michelle R. Wise et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Metformin targeting autophagy overcomes progesterone resistance in endometrial carcinoma
- (2016) Zhihong Zhuo et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Measuring the biological effect of presurgical metformin treatment in endometrial cancer
- (2016) V N Sivalingam et al. BRITISH JOURNAL OF CANCER
- Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway
- (2016) Jingfang Zou et al. CANCER SCIENCE
- Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
- (2016) Navdeep S. Chandel et al. Cell Metabolism
- Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
- (2016) Roberto Würth et al. DRUG DISCOVERY TODAY
- The prognostic role of metformin in patients with endometrial cancer: a retrospective study
- (2016) Veronika Seebacher et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
- (2016) Mariam M. Al Hilli et al. GYNECOLOGIC ONCOLOGY
- Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis
- (2016) Angeles Alvarez Secord et al. GYNECOLOGIC ONCOLOGY
- Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
- (2016) Pamela T. Soliman et al. GYNECOLOGIC ONCOLOGY
- Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence
- (2016) Christopher Hall et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer
- (2016) Dongge Cai et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines
- (2016) Ido Laskov et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
- (2016) Cristovão M. Sousa et al. NATURE
- Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin
- (2016) Eui Hyun Kim et al. NEURO-ONCOLOGY
- The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development
- (2016) Jun Gong et al. Targeted Oncology
- Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning
- (2016) HARUKO IRIE et al. Oncology Letters
- Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment
- (2016) Amanda de Barros Machado et al. Oncology Letters
- Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells
- (2016) Zhao Liu et al. Oncotarget
- Repurposing metformin for cancer treatment: current clinical studies
- (2016) Young Kwang Chae et al. Oncotarget
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
- (2016) Stephanos Pavlides et al. Aging-US
- Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy
- (2016) Obiageli Ezewuiro et al. PLoS One
- Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
- (2015) A. Mitsuhashi et al. ANNALS OF ONCOLOGY
- Anthropometric factors and endometrial cancer risk: a systematic review and dose–response meta-analysis of prospective studies
- (2015) D. Aune et al. ANNALS OF ONCOLOGY
- Antiproliferative Effect of Metformin on the Endometrium - a Clinical Trial
- (2015) Ali Dastranj Tabrizi et al. Asian Pacific Journal of Cancer Prevention
- Metformin Down-regulates Endometrial Carcinoma Cell Secretion of IGF-1 and Expression of IGF-1R
- (2015) Yu Zhang et al. Asian Pacific Journal of Cancer Prevention
- Repurposing metformin: an old drug with new tricks in its binding pockets
- (2015) R. Pryor et al. BIOCHEMICAL JOURNAL
- Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER-Medicare Linked Database
- (2015) B. Trabert et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma
- (2015) J. Ni et al. Clinical & Translational Oncology
- Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
- (2015) I. L. Romero et al. CLINICAL CANCER RESEARCH
- Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms
- (2015) T. Byers et al. ENDOCRINE-RELATED CANCER
- Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
- (2015) Adrian V. Hernandez et al. EUROPEAN JOURNAL OF CANCER
- Do endometrial cancer patients benefit from metformin intake?
- (2015) Agnieszka Lemańska et al. Ginekologia Polska
- Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan
- (2015) Chin-Hsiao Tseng GYNECOLOGIC ONCOLOGY
- The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo
- (2015) Stefanie Schrauwen et al. GYNECOLOGIC ONCOLOGY
- Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling
- (2015) Jianjun Han et al. GYNECOLOGIC ONCOLOGY
- Metformin and the risk of endometrial cancer: A population-based cohort study
- (2015) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- Metabolic risk score and cancer risk: pooled analysis of seven cohorts
- (2015) Tanja Stocks et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Clinical benefits of metformin in gynecologic oncology
- (2015) ATSUSHI IMAI et al. Oncology Letters
- Expanding the therapeutic spectrum of metformin: from diabetes to cancer
- (2015) F. Coperchini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
- (2015) Jie Yuan et al. Scientific Reports
- Association between diabetes, diabetes treatment and risk of developing endometrial cancer
- (2014) J Luo et al. BRITISH JOURNAL OF CANCER
- Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial
- (2014) Akira Mitsuhashi et al. CANCER
- Modeling Alveolar Soft Part Sarcomagenesis in the Mouse: A Role for Lactate in the Tumor Microenvironment
- (2014) Matthew L. Goodwin et al. CANCER CELL
- Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
- (2014) Akimasa Takahashi et al. Cancer Cell International
- Metabolic Vulnerabilities in Endometrial Cancer
- (2014) F. L. Byrne et al. CANCER RESEARCH
- The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
- (2014) Z.-J. Zhang et al. DIABETES OBESITY & METABOLISM
- AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1
- (2014) Hee Yun et al. FEBS Journal
- Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer
- (2014) Ido Laskov et al. GYNECOLOGIC ONCOLOGY
- Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor
- (2014) Brent J. Tierney et al. GYNECOLOGIC ONCOLOGY
- Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies
- (2014) Caiyun Liao et al. GYNECOLOGIC ONCOLOGY
- Old drug, new trick: Repurposing metformin for gynecologic cancers?
- (2014) Terri Febbraro et al. GYNECOLOGIC ONCOLOGY
- Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predisposition
- (2014) Gemma L. Moir-Meyer et al. HUMAN GENETICS
- Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis
- (2014) John A. Barry et al. HUMAN REPRODUCTION UPDATE
- Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro
- (2014) TAKASHI UEHARA et al. ONCOLOGY REPORTS
- Regulation of insulin-like growth factor signaling by metformin in endometrial cancer cells
- (2014) YA XIE et al. Oncology Letters
- Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance
- (2014) Xin Li et al. Journal of Cancer
- Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
- (2014) Kevin M. Schuler et al. Cancer Medicine
- Hormonal, Metabolic, and Inflammatory Profiles and Endometrial Cancer Risk Within the EPIC Cohort—A Factor Analysis
- (2013) Laure Dossus et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
- (2013) Emelie Karnevi et al. BMC CANCER
- Inhibition of Lung Tumorigenesis by Metformin Is Associated with Decreased Plasma IGF-I and Diminished Receptor Tyrosine Kinase Signaling
- (2013) B. J. Quinn et al. Cancer Prevention Research
- Metformin and the risk of endometrial cancer: A case–control analysis
- (2013) Claudia Becker et al. GYNECOLOGIC ONCOLOGY
- Metformin use and endometrial cancer survival
- (2013) Nicole S. Nevadunsky et al. GYNECOLOGIC ONCOLOGY
- Metformin is associated with improved survival in endometrial cancer
- (2013) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- The expression and functionality of stromal caveolin 1 in human adenomyosis
- (2013) L. Zhao et al. HUMAN REPRODUCTION
- Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy
- (2013) D. A. Iglesias et al. MOLECULAR CANCER THERAPEUTICS
- Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners
- (2013) Rive Sarfstein et al. PLoS One
- Cancer drug discovery by repurposing: teaching new tricks to old dogs
- (2013) Subash C. Gupta et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?
- (2013) Anna Markowska et al. Diabetology & Metabolic Syndrome
- Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells
- (2012) Ying-Hui Ko et al. CANCER BIOLOGY & THERAPY
- Reciprocal Metabolic Reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay
- (2012) T. Fiaschi et al. CANCER RESEARCH
- Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis
- (2012) K. Esposito et al. DIABETES CARE
- Uterine papillary serous cancer: A review of the literature
- (2012) Marcela G. del Carmen et al. GYNECOLOGIC ONCOLOGY
- Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway
- (2012) Rabbie K. Hanna et al. GYNECOLOGIC ONCOLOGY
- Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression
- (2012) Lingling Dong et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Adjuvant Radiotherapy for Stage I Endometrial Cancer: An Updated Cochrane Systematic Review and Meta-analysis
- (2012) A. Kong et al. JNCI-Journal of the National Cancer Institute
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
- (2012) M A Pierotti et al. ONCOGENE
- Case-Control Study of the Metabolic Syndrome and Metabolic Risk Factors for Endometrial Cancer
- (2011) C. M. Friedenreich et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- Evidence for a stromal-epithelial “lactate shuttle” in human tumors
- (2011) Diana Whitaker-Menezes et al. CELL CYCLE
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
- (2011) X. Stephenne et al. DIABETOLOGIA
- Metformin Reverses Progestin Resistance in Endometrial Cancer Cells by Downregulating GloI Expression
- (2011) Zhenbo Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Metabolic Syndrome and Endometrial Carcinoma
- (2010) T. Bjorge et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Metabolic syndrome and endometrial cancer risk
- (2010) V. Rosato et al. ANNALS OF ONCOLOGY
- The reverse Warburg Effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts
- (2010) Gloria Bonuccelli et al. CELL CYCLE
- HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells
- (2010) Barbara Chiavarina et al. CELL CYCLE
- Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution
- (2010) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- The association between metabolic abnormality and endometrial cancer: A large case-control study in China
- (2010) Yan Zhang et al. GYNECOLOGIC ONCOLOGY
- Metformin Treatment Exerts Antiinvasive and Antimetastatic Effects in Human Endometrial Carcinoma Cells
- (2010) Bee K. Tan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells
- (2010) Ya Xie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- (2010) RA Nout et al. LANCET
- AMP-Activated Protein Kinase Inhibits IGF-I Signaling and Protein Synthesis in Vascular Smooth Muscle Cells via Stimulation of Insulin Receptor Substrate 1 S794 and Tuberous Sclerosis 2 S1345 Phosphorylation
- (2010) Junyu Ning et al. MOLECULAR ENDOCRINOLOGY
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
- (2009) Leigh A. Cantrell et al. GYNECOLOGIC ONCOLOGY
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
- (2009) LANCET
- Metabolic syndrome and cancer risk
- (2007) Antonio Russo et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now